The Role of Excitotoxicity in Neurodegenerative Disease-Reference-Cited by-同舟云学术

The Role of Excitotoxicity in Neurodegenerative Disease

Published:1999-03 Issue:3 Volume:81 Page:163-221
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Doble Adam

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference693 articles.

1. The primary afferent depolarizing action of kainate in the rat;Agrawal;Br. J. Pharmacol.,1986

2. Selective modulation of NMDA responses by reduction and oxidation;Aizenman;Neuron,1989

3. Spider toxin blocks excitatory amino acid responses in isolated hippocampal pyramidal neurones;Akaike;Neurosci. Lett.,1987

4. Safety, tolerability, and pharmacokinetics of the N-methyl-d-aspartate antagonist dextrorphan in patients with an acute stroke;Albers;Dextrorphan Study Group. Stroke,1995

5. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease;Andrew;Nature Genet.,1993

Cited by 626 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uptake of β-N-methylamino-L-alanine (BMAA) into glutamate-specific synaptic vesicles: Exploring the validity of the excitotoxicity mechanism of BMAA;Neuroscience Letters;2024-01

2. Graphene Oxide Nanosheets Hamper Glutamate Mediated Excitotoxicity and Protect Neuronal Survival In An In vitro Stroke Model;Chemistry – A European Journal;2023-10-20

3. Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View;Cells;2023-09-20

4. Bioactive Nutraceuticals for Amyotrophic Lateral Sclerosis;Exploring Complementary and Alternative Medicinal Products in Disease Therapy;2023-08-29

5. From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research;International Journal of Molecular Sciences;2023-08-21